Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 3 23Phase 1 8Phase 2/3 4Phase NA 3Phase 4 2Phase 1/2 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 3Esophageal Neoplasms 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Tegafur × Clear all
NCT05817201 2023-04-18

Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy

Taizhou Hospital

Phase 2/3 Unknown
60 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT05325528 2023-02-01

Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases

Zhejiang University

Phase 2/3 Unknown
40 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01516944 2020-02-13

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Hebei Medical University

Phase 2/3 Completed
749 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00503321 2009-01-23

eNCIT-Japan

Eastern Network of Cancer Immunological Therapy, Japan

Phase 2/3 Terminated
13 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡